U.S. markets closed

Danaher Corporation (DHR)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
217.49-1.43 (-0.65%)
Al cierre: 04:00PM EST
217.20 -0.29 (-0.13%)
Fuera de horario: 07:52PM EST

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Sector(es)Healthcare
IndustriaDiagnostics & Research
Empleados a tiempo completo79,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Steven M. RalesCo-Founder & ChairmanN/DN/D1951
Mr. Rainer M. BlairPresident, CEO & Director5.93M5.83M1964
Mr. Mitchell P. RalesCo-Founder & DirectorN/DN/D1957
Mr. Matthew R. McGrewCFO & Executive VP2.85M4.12M1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer2.24MN/D1963
Mr. Joakim WeidemanisExecutive Vice President3.13M6.28M1969
Mr. Christopher M. BoudaVP & Chief Accounting OfficerN/DN/DN/D
Mr. John BedfordVice President of Investor RelationsN/DN/DN/D
Mr. Brian W. EllisSenior VP, General Counsel & Chief Compliance Officer1.93MN/D1967
Mr. Daniel A. Raskas J.D.Senior Vice President of Corporate DevelopmentN/DN/D1967
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Gestión corporativa

La calificación ISS Governance QuickScore de Danaher Corporation a partir del 1 de diciembre de 2023 es 7. Las puntuaciones principales son Auditoría: 8; Junta: 10; Derechos del accionista: 2; Compensación: 1.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.